GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This trial is designed to investigate the efficacy and safety of GM-CSF used as a maintenance
program in patients with androgen-independent prostate cancer (AIPC) who have achieved a
maximal response on a taxotere or other chemotherapy schedule.